FYERS
Home
/
Stocks
/
Results
/
iSERA Lifesciences Results

iSERA Lifesciences Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
-31%-34%-0%
2%--241%
-169%306%1408%
-717%-1372%0%0%

Peer Comparison

Symbol
TCS-A
INFY-A
HCLTECH-A
WIPRO-A
TECHM-A
LTM-A
PERSISTENT-A
OFSS-A
COFORGE-A
MPHASIS-A
ISERA-XT
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
2,302₹820220 Cr15.8938.35157.25₹49210 Cr
1,088.9₹431070 Cr14.2319.1886.97₹29440 Cr
1,329₹358475 Cr19.5718.983.25₹16642 Cr
171₹167296 Cr12.663.3816.4₹13197 Cr
1,576₹151148 Cr29.4316.5471.8₹4811 Cr
4,230₹124729 Cr23.8549.54212.49₹5018 Cr
5,891.35₹94650 Cr49.2130.62148.82₹1865 Cr
10,472₹92552 Cr27.12162.7398.99₹2639 Cr
1,929₹85327 Cr48.5711.7256.9₹1556 Cr
2,443.55₹47069 Cr24.6425.64129.92₹1863 Cr
143.9₹354 Cr—-0.4-0.02₹26 L

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015Mar 2015Dec 2014Sep 2014Jun 2014Mar 2014Dec 2013Sep 2013Jun 2013Mar 2013Dec 2012Sep 2012Jun 2012Mar 2012Dec 2011Sep 2011
₹0₹1 Cr₹19 L₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹90,000₹0₹1 Cr₹1 Cr₹28 L₹87 L₹73 L₹10 Cr₹13 Cr₹8 Cr₹4 Cr₹4 Cr₹4 Cr₹5 Cr₹5 Cr₹7 Cr₹2 Cr₹13 Cr₹6 Cr₹4 Cr₹2 Cr₹4 Cr₹2 Cr₹3 Cr₹9 L₹6 Cr₹8 Cr₹10 Cr₹9 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr
₹0₹6 L₹20,000₹1 L₹0₹27 L₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹10,000₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹15 L₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹4 L₹0₹0₹0₹3 L₹2 L₹0₹0
₹0₹1 Cr₹20 L₹1 L₹0₹27 L₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹10,000₹0₹0₹0₹90,000₹0₹1 Cr₹1 Cr₹28 L₹87 L₹73 L₹10 Cr₹13 Cr₹8 Cr₹4 Cr₹4 Cr₹4 Cr₹5 Cr₹6 Cr₹7 Cr₹2 Cr₹13 Cr₹6 Cr₹4 Cr₹2 Cr₹4 Cr₹2 Cr₹3 Cr₹9 L₹6 Cr₹8 Cr₹10 Cr₹9 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr
₹34 L₹59 L₹48 L₹30,000₹2 L₹4 L₹7 L₹1 L₹1 L₹7 L₹1 L₹2 L₹1 L₹2 L₹2 L₹6 L₹2 L₹0₹2 L₹2 L₹4 L₹20,000₹0₹5 L₹6 L₹12 L₹3 L₹1 Cr₹1 Cr₹19 L₹82 L₹69 L₹10 Cr₹13 Cr₹8 Cr₹4 Cr₹4 Cr₹4 Cr₹5 Cr₹6 Cr₹7 Cr₹2 Cr₹13 Cr₹6 Cr₹4 Cr₹2 Cr₹4 Cr₹2 Cr₹3 Cr₹1 Cr₹6 Cr₹7 Cr₹9 Cr₹8 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr
-₹34 L₹63 L-₹28 L₹70,000-₹2 L₹23 L-₹7 L-₹1 L-₹1 L-₹7 L-₹1 L-₹2 L-₹1 L-₹2 L-₹2 L-₹6 L-₹2 L-₹10,000-₹10,000-₹20,000-₹50,000-₹10,000₹0-₹2 L-₹2 L₹2 L-₹3 L-₹3 L-₹50,000₹17 L₹5 L₹4 L₹8 L₹21 L₹12 L₹8 L₹5 L-₹3 L₹16 L₹16 L₹16 L-₹59 L₹37 L₹22 L₹20 L₹45 L₹6 L₹2 L₹6 L-₹98 L₹18 L₹61 L₹82 L₹2 Cr₹17 L₹2 L₹5 L₹5 L₹3 L₹3 L
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹10,000₹2 L₹1 L₹7 L₹5 L₹5 L₹6 L₹9 L₹5 L₹5 L₹5 L₹9 L₹6 L₹7 L₹5 L₹5 L₹5 L₹6 L₹4 L₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
-₹34 L₹63 L-₹28 L₹70,000-₹2 L₹23 L-₹7 L-₹1 L-₹1 L-₹7 L-₹1 L-₹2 L-₹1 L-₹2 L-₹2 L-₹6 L-₹2 L₹0-₹2 L-₹2 L-₹4 L-₹10,000-₹10,000-₹7 L-₹7 L-₹18 L-₹8 L-₹9 L-₹6 L-₹50,000-₹40,000-₹1 L₹3 L₹60,000₹2 L₹90,000₹80,000-₹6 L₹4 L₹3 L₹3 L-₹40 L₹28 L₹13 L₹11 L₹90,000₹4 L₹10,000₹4 L-₹1 Cr₹17 L₹58 L₹80 L₹2 Cr₹16 L₹2 L₹4 L₹4 L₹3 L₹2 L
-₹34 L₹55 L-₹28 L₹70,000-₹2 L₹23 L-₹7 L-₹1 L-₹1 L-₹7 L-₹1 L-₹2 L-₹1 L-₹2 L-₹2 L-₹6 L-₹2 L₹0-₹2 L-₹2 L-₹4 L-₹10,000-₹10,000-₹7 L-₹7 L-₹19 L-₹8 L-₹9 L-₹6 L-₹2 L-₹40,000-₹1 L₹2 L₹1 L₹1 L₹60,000₹60,000-₹6 L₹3 L₹2 L₹2 L-₹13 Cr₹20 L₹9 L₹8 L₹6 L₹3 L₹10,000₹3 L-₹1 Cr₹11 L₹41 L₹54 L₹1 Cr₹12 L₹1 L₹3 L₹3 L₹2 L₹1 L

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Total Non-Current Assets
Current Assets Loans & Advances
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008
——————————————————
₹32 L₹32 L₹30 L₹0₹11 Cr₹11 Cr₹11 Cr₹11 Cr₹11 Cr₹11 Cr₹11 Cr₹11 Cr₹11 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr
₹0₹10,000₹10,000₹30 L₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
-₹42 L-₹54 L-₹42 L-₹31 L-₹11 Cr-₹10 Cr-₹10 Cr-₹10 Cr-₹10 Cr-₹10 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr
-₹42 L-₹54 L-₹42 L-₹31 L-₹11 Cr-₹10 Cr-₹10 Cr-₹10 Cr-₹10 Cr-₹10 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr
-₹10 L-₹22 L-₹12 L-₹45,118-₹11 L₹11 L₹53 L₹55 L₹51 L₹50 L₹13 Cr₹13 Cr₹13 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr
₹0₹0₹0₹0₹0₹8 L₹14 L₹19 L₹22 L₹26 L₹0₹0₹0₹0₹0₹0₹0₹0
₹2 Cr₹18 L₹13 L₹0₹2 Cr₹6 Cr₹6 Cr₹6 Cr₹5 Cr₹4 Cr₹5 Cr₹4 Cr₹1 Cr₹0₹0₹0₹0₹0
₹0₹0₹0₹0₹4 L₹4 L₹2 L-₹38,345₹1,156₹2 L₹3 L₹3 L₹3 L₹84,002₹1 L₹66,959₹26,965-₹4,485
₹2 Cr₹18 L₹13 L₹0₹2 Cr₹7 Cr₹6 Cr₹6 Cr₹5 Cr₹5 Cr₹5 Cr₹4 Cr₹1 Cr₹84,002₹1 L₹66,959₹26,965-₹4,485
——————————————————
₹2 L₹3 L₹0₹0₹2 Cr₹3 Cr₹3 Cr₹6 Cr₹3 Cr₹3 Cr₹1 Cr₹2 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹6 L
₹30,000₹5 L₹4 L₹55,000₹25,000₹15 L₹19 L₹57 L₹97 L₹36 L₹0₹0₹0₹0₹0₹3 L₹4 L₹3 L
₹0₹0₹0₹0₹0₹0₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹0₹0₹0₹0₹0₹0₹0₹0
₹2 L₹0₹0₹0₹74 L₹75 L₹74 L₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹3 L₹8 L₹6 L₹4 L₹3 L
₹5 L₹9 L₹4 L₹55,000₹3 Cr₹4 Cr₹6 Cr₹10 Cr₹7 Cr₹6 Cr₹2 Cr₹4 Cr₹5 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹11 L
₹2 Cr₹5 L₹5 L₹9,882₹4 Cr₹10 Cr₹12 Cr₹16 Cr₹13 Cr₹11 Cr₹21 Cr₹21 Cr₹19 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹5 Cr
₹2 Cr₹18 L₹13 L₹0₹2 Cr₹7 Cr₹8 Cr₹7 Cr₹7 Cr₹6 Cr₹5 Cr₹4 Cr₹1 Cr₹0₹0₹0₹0₹0
——————————————————
₹0₹0₹0₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹8 Cr₹5 Cr₹4 Cr₹38 L₹38 L₹34 L₹31 L₹28 L
₹0₹0₹0₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹96 L₹82 L₹61 L₹96 L₹45 L₹35 L₹31 L₹29 L₹27 L₹25 L₹24 L
₹0₹0₹0₹0₹43 L₹62 L₹75 L₹45 L₹44 L₹48 L₹7 Cr₹5 Cr₹4 Cr₹7 L₹9 L₹7 L₹6 L₹4 L
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹2 Cr₹3 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹4 Cr₹4 Cr₹4 Cr₹69 L₹69 L₹69 L₹69 L₹69 L
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹4 Cr₹4 Cr₹4 Cr₹69 L₹69 L₹69 L₹69 L₹69 L
₹0₹0₹0₹0₹43 L₹62 L₹75 L₹45 L₹44 L₹48 L₹13 Cr₹12 Cr₹12 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr
——————————————————
₹31 L₹0₹0₹0₹3 Cr₹9 Cr₹10 Cr₹14 Cr₹10 Cr₹9 Cr₹6 Cr₹8 Cr₹6 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹32 L
₹2 L₹14,005₹27,623₹9,882₹31,041₹91,910₹78,246₹70,981₹1 L₹3 L₹4 L₹76,785₹5 L₹81,247₹4 L₹5 L₹4 L₹6 L
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹13,560₹13,560₹35,480₹25,480
₹1 Cr₹5 L₹5 L₹0₹1 Cr₹1 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹27 L₹21 L₹13 L₹13 L₹12 L₹9 L₹6 L
₹2 Cr₹5 L₹5 L₹9,882₹4 Cr₹10 Cr₹11 Cr₹16 Cr₹12 Cr₹11 Cr₹8 Cr₹9 Cr₹7 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹44 L
₹2 Cr-₹3 L₹88,526-₹45,118₹2 Cr₹6 Cr₹6 Cr₹6 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹2 Cr₹51 L₹43 L₹38 L₹34 L₹33 L
₹2 Cr₹5 L₹5 L₹9,882₹4 Cr₹10 Cr₹12 Cr₹16 Cr₹13 Cr₹11 Cr₹21 Cr₹21 Cr₹19 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹5 Cr
-₹3-₹7-₹4₹0-₹0₹0₹1₹1₹0₹0₹12₹12₹12₹15₹15₹14₹14₹14
-₹3-₹7-₹4₹0-₹0₹0₹1₹1₹0₹0₹12₹12₹12₹15₹15₹14₹14₹14

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008
₹14 L-₹10 L-₹11 L-₹11 L-₹22 L-₹40 L₹86,975₹4 L₹49,127-₹13 Cr₹12 L₹4 L₹1 Cr₹92,763₹9 L₹7 L₹5 L₹1,791
₹0₹0₹0₹0₹10 L₹14 L₹11 L₹14 L₹17 L₹13 Cr₹47 L₹10 L₹10 L₹2 L₹2 L₹2 L₹1 L₹1 L
-₹2 Cr₹4 L-₹1 L-₹19 L₹5 Cr₹1 Cr₹25 L-₹69 L-₹81 L₹65 L-₹9 L-₹3 Cr-₹2 Cr-₹6 L-₹8 L-₹8 L-₹8 L-₹2 L
-₹1 Cr-₹6 L-₹12 L-₹30 L₹4 Cr₹99 L₹37 L-₹51 L-₹63 L₹81 L₹50 L-₹3 Cr-₹84 L-₹3 L₹3 L₹30,312-₹1 L-₹73,100
-₹1 Cr-₹6 L-₹12 L-₹30 L₹4 Cr₹97 L₹34 L-₹51 L-₹63 L₹81 L₹50 L-₹3 Cr-₹84 L-₹3 L₹3 L₹30,312-₹1 L-₹73,100
₹0₹0₹0₹0₹10 L₹0-₹38 L-₹16 L-₹16 L-₹40 L-₹1 Cr-₹5 L-₹7 Cr₹0-₹4 L₹0₹0₹0
₹1 Cr₹6 L₹13 L₹30 L-₹5 Cr-₹97 L₹4 L₹66 L₹77 L-₹42 L₹69 L₹3 Cr₹8 Cr₹0₹0₹0₹0₹0
₹2 L-₹13,618₹17,741₹9,882-₹60,869₹13,663₹7,266-₹52,178-₹2 L-₹1 L₹4 L-₹4 L₹4 L-₹3 L-₹85,609₹30,312-₹1 L-₹73,100
₹14,000₹27,623₹9,882₹0₹91,910₹78,247₹70,981₹1 L₹3 L₹4 L₹76,785₹5 L₹81,247₹4 L₹5 L₹4 L₹6 L₹7 L
₹2 L₹14,005₹27,623₹9,882₹31,041₹91,910₹78,247₹70,981₹1 L₹3 L₹4 L₹76,785₹5 L₹81,246₹4 L₹5 L₹4 L₹6 L

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)143.90
Volume (₹)14.00
High (₹)143.90
Upper Circuit143.90
Low (₹)143.90
Lower Circuit136.75
Prev Close143.90
52W High (₹)151.05
Price143.90
52W Low (₹)7.99

Share Market Cap & Key Ratios Overview

M.Cap (₹)353.88 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity-16.38
Price to Book0.00
Book Value-3.83
EPS (TTM)-0.02
Face Value10.00
ROE (%)0.00

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
TCS-ANSE
INFY-ANSE
HCLTECH-ANSE
WIPRO-ANSE
TECHM-ANSE
LTM-ANSE
PERSISTENT-ANSE
OFSS-ANSE
COFORGE-ANSE
MPHASIS-ANSE
ISERA-XTNSE
LTP
1W Low
1W High
Market cap (₹)
2302+139 (6.43%)
2121
2335.45
8,20,220Cr
1088.9+64.85 (6.33%)
1010.40
1095.90
4,31,070Cr
1329+114.7 (9.45%)
1206.50
1353.80
3,58,475Cr
171+8.3 (5.10%)
161.05
172.40
1,67,296Cr
1576+58.95 (3.89%)
1443
1581.90
1,51,148Cr
4230+164.85 (4.06%)
4001.20
4306.25
1,24,729Cr
5891.35+161.65 (2.82%)
5737
6080
94,650Cr
10472-3.1 (-0.03%)
10286.65
10690.70
92,552Cr
1929+61 (3.27%)
1836.80
1965.30
85,327Cr
2443.55+93.45 (3.98%)
2317.10
2508.10
47,069Cr
143.9+0 (0.00%)
143.90
143.90
354Cr

iSERA Lifesciences Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹20.6Lakh; with other income of ₹0 cr, profit before interest and tax came to ₹11.9Lakh. Interest expense was ₹13.1Lakh; PBT before exceptional items stood at ₹-₹1.2Lakh. Basis: consolidated annual results.

iSERA Lifesciences Ltd Quaterly Results Key Takeaways

iSERA Lifesciences Ltd reported ₹3.62Cr total income from operations in Mar 2019, softer than ₹13.79Cr in Mar 2018 but higher than ₹2.26Cr in Mar 2015. Operating profit (before other income, interest and exceptional items) was ₹20.6Lakh; with other income of ₹0 cr, profit before interest and tax came to ₹11.9Lakh. Interest expense was ₹13.1Lakh, taking profit before tax to ₹-₹1.2Lakh. After tax of ₹1.5Lakh, profit after tax stood at ₹-₹2.7Lakh (vs ₹40000 cr in Mar 2018 and ₹6.3Lakh in Mar 2015).